HIGHLIGHTS
- who: Tomasz Bogiel and collaborators from the In total, clinical isolates of imipenem- and meropenem-resistant Paeruginosa strains were included in the study. The strains were initially identified based on typical growth on a selective medium (Cetrimide agar, bioMérieux, France) and biochemical reaction results. The final identification was made using a MALDI-TOF MS device (Bruker, Mannheim, Germany). All the strains were also initially screened for the presence of MBLs, OXA-like and Klebsiella pneumoniae carbapenemases (KPC) enzymes (data not shown). All of them were isolated in the Clinical Microbiology Laboratory of Dr Antoni Jurasz University . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.